Looking Into Ginkgo Bioworks Holdings's Recent Short Interest Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 9.65% since its last report. The company recently reported that it has 81.30 million shares sold short, which is 10.34% of all regular shares that are available for trading. Benzinga · May 13, 2022
8 Materials Stocks Moving In Tuesday's Pre-Market Session Gainers Ginkgo Bioworks Holdings (NYSE:DNA) shares rose 9.9% to $4.11 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.8 billion. The company's, Q4 earnings came out yesterday. Benzinga · Mar 29, 2022
Should You Add Ginkgo Bioworks Holdings to Your Biotech Portfolio? Ginkgo Bioworks (DNA) went public last September through an SPAC deal with Soaring Eagle Acquisition Corporation, a blank-check company led by former MGM CEO Harry Sloan. However, the stock has nosedived in price since its market debut. In addition, given an ongoing investigation into the company and its weak financials,… StockNews.com · Feb 8, 2022